Response to "Prevalence, Risk Factors, and Mortality of Invasive Pulmonary Aspergillosis in Patients with Anti-MDA5 + Dermatomyositis: A Retrospective Study in China" [Letter].
作者信息
Prisusanti Retno Dewi, Suhariyono Untung Slamet, Mahdi Chanif
机构信息
Medical Record and Health Information Department, ITSK RS DR Soepraoen Malang, Kota Malang, Jawa Timur, Indonesia.
出版信息
J Inflamm Res. 2024 Jun 5;17:3653-3654. doi: 10.2147/JIR.S479288. eCollection 2024.
Abstract
摘要
相似文献
1
Response to "Prevalence, Risk Factors, and Mortality of Invasive Pulmonary Aspergillosis in Patients with Anti-MDA5 + Dermatomyositis: A Retrospective Study in China" [Letter].对《抗MDA5阳性皮肌炎患者侵袭性肺曲霉病的患病率、危险因素及死亡率：一项中国的回顾性研究》[信函]的回应
J Inflamm Res. 2024 Jun 5;17:3653-3654. doi: 10.2147/JIR.S479288. eCollection 2024.
2
Prevalence, Risk Factors, and Mortality of Invasive Pulmonary Aspergillosis in Patients with Anti-MDA5+ Dermatomyositis: A Retrospective Study in China.抗MDA5阳性皮肌炎患者侵袭性肺曲霉病的患病率、危险因素及死亡率：一项中国的回顾性研究
J Inflamm Res. 2024 May 20;17:3247-3257. doi: 10.2147/JIR.S460702. eCollection 2024.
3
Comparison of characteristics and anti-MDA5 antibody distribution and effect between clinically amyopathic dermatomyositis and classic dermatomyositis: a retrospective case-control study.临床无肌病性皮肌炎与经典皮肌炎特征及抗 MDA5 抗体分布和疗效比较：一项回顾性病例对照研究。
Front Immunol. 2023 Nov 27;14:1237209. doi: 10.3389/fimmu.2023.1237209. eCollection 2023.
4
[Three cases report of juvenile dermatomyositis with positive anti-melanoma differentiation associated gene 5 (MDA5) antibody and severe interstitial lung disease and literature review].[三例抗黑色素瘤分化相关基因5（MDA5）抗体阳性且伴有严重间质性肺疾病的青少年皮肌炎病例报告及文献复习]
Zhonghua Er Ke Za Zhi. 2019 Dec 2;57(12):928-933. doi: 10.3760/cma.j.issn.0578-1310.2019.12.007.
5
Spontaneous pneumomediastinum in anti-MDA5-positive dermatomyositis: Prevalence, risk factors, and prognosis.抗 MDA5 阳性皮肌炎中的自发性纵隔气肿：患病率、危险因素和预后。
Semin Arthritis Rheum. 2024 Apr;65:152352. doi: 10.1016/j.semarthrit.2023.152352. Epub 2024 Jan 3.
6
[Value of serum YKL-40 in the diagnosis of anti-MDA5-positive patients with dermatomyositis complicated with severe pulmonary injury].血清YKL-40在抗MDA5阳性皮肌炎合并严重肺损伤患者诊断中的价值
Beijing Da Xue Xue Bao Yi Xue Ban. 2021 Dec 18;53(6):1055-1060. doi: 10.19723/j.issn.1671-167X.2021.06.008.
7
Mortality risk in patients with anti-MDA5 dermatomyositis is related to rapidly progressive interstitial lung disease and anti-Ro52 antibody.抗 MDA5 皮肌炎患者的死亡率与快速进展性间质性肺病和抗 Ro52 抗体有关。
Arthritis Res Ther. 2023 Jul 24;25(1):127. doi: 10.1186/s13075-023-03100-z.
8
Characteristics and prognostic implications of peripheral blood lymphocyte subsets in patients with anti-MDA5 antibody positive dermatomyositis-interstitial lung disease.抗 MDA5 抗体阳性皮肌炎-间质性肺病患者外周血淋巴细胞亚群特征及其预后意义。
BMC Pulm Med. 2023 Oct 28;23(1):411. doi: 10.1186/s12890-023-02706-y.
9
Prognosis of spontaneous pneumomediastinum occurring in dermatomyositis or polymyositis patients with interstitial lung disease according to antimelanoma differentiation-associated gene 5 antibody status: a retrospective cohort study.特发性皮肌炎/多发性肌炎合并间质性肺病患者发生自发性纵隔气肿的预后与抗黑色素瘤分化相关基因 5 抗体状态的关系：一项回顾性队列研究。
RMD Open. 2023 Feb;9(1). doi: 10.1136/rmdopen-2022-002770.
10
Differences in the Clinical Characteristics and 1-Year Mortality Rates of Patients with Dermatomyositis with anti-Jo-1 and anti-MDA5 Antibodies.抗-Jo-1 抗体和抗 MDA5 抗体阳性皮肌炎患者的临床特征和 1 年死亡率的差异。
J Immunol Res. 2023 Jan 4;2023:2988422. doi: 10.1155/2023/2988422. eCollection 2023.
本文引用的文献
1
Prevalence, Risk Factors, and Mortality of Invasive Pulmonary Aspergillosis in Patients with Anti-MDA5+ Dermatomyositis: A Retrospective Study in China.抗MDA5阳性皮肌炎患者侵袭性肺曲霉病的患病率、危险因素及死亡率：一项中国的回顾性研究
J Inflamm Res. 2024 May 20;17:3247-3257. doi: 10.2147/JIR.S460702. eCollection 2024.
2
A systematic review of epidemiology, risk factors, diagnosis, antifungal resistance, and management of invasive aspergillosis in Africa.非洲侵袭性曲霉病的流行病学、危险因素、诊断、抗真菌耐药性及管理的系统评价
J Mycol Med. 2023 Mar;33(1):101328. doi: 10.1016/j.mycmed.2022.101328. Epub 2022 Aug 24.
3
Consensus guidelines for the diagnosis and management of invasive aspergillosis, 2021.侵袭性曲霉病诊断与管理共识指南，2021 年版。
Intern Med J. 2021 Nov;51 Suppl 7:143-176. doi: 10.1111/imj.15591.
4
Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline.曲霉病的诊断和治疗：2017 年 ESCMID-ECMM-ERS 指南执行摘要。
Clin Microbiol Infect. 2018 May;24 Suppl 1:e1-e38. doi: 10.1016/j.cmi.2018.01.002. Epub 2018 Mar 12.
Zotero 插件